Free Trial
NYSE:RMD

ResMed (RMD) Stock Price, News & Analysis

ResMed logo
$258.09 +2.11 (+0.83%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$254.90 -3.19 (-1.24%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ResMed Stock (NYSE:RMD)

Key Stats

Today's Range
$255.60
$261.08
50-Day Range
$239.84
$258.24
52-Week Range
$195.00
$263.05
Volume
637,776 shs
Average Volume
965,483 shs
Market Capitalization
$37.84 billion
P/E Ratio
28.97
Dividend Yield
0.82%
Price Target
$259.33
Consensus Rating
Moderate Buy

Company Overview

ResMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

RMD MarketRank™: 

ResMed scored higher than 94% of companies evaluated by MarketBeat, and ranked 75th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ResMed has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 8 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    ResMed has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about ResMed's stock forecast and price target.
  • Earnings Growth

    Earnings for ResMed are expected to grow by 9.40% in the coming year, from $9.47 to $10.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ResMed is 28.97, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ResMed is 28.97, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

  • Price to Earnings Growth Ratio

    ResMed has a PEG Ratio of 1.60. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    ResMed has a P/B Ratio of 7.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about ResMed's valuation and earnings.
  • Percentage of Shares Shorted

    6.82% of the float of ResMed has been sold short.
  • Short Interest Ratio / Days to Cover

    ResMed has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in ResMed has recently decreased by 6.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ResMed has a dividend yield of 0.83%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    ResMed has been increasing its dividend for 13 years.

  • Dividend Coverage

    The dividend payout ratio of ResMed is 23.79%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, ResMed will have a dividend payout ratio of 20.46% next year. This indicates that ResMed will be able to sustain or increase its dividend.

  • Read more about ResMed's dividend.
  • Percentage of Shares Shorted

    6.82% of the float of ResMed has been sold short.
  • Short Interest Ratio / Days to Cover

    ResMed has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in ResMed has recently decreased by 6.23%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ResMed has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for ResMed this week, compared to 17 articles on an average week.
  • Search Interest

    4 people have searched for RMD on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added ResMed to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ResMed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,238,913.00 in company stock.

  • Percentage Held by Insiders

    Only 0.71% of the stock of ResMed is held by insiders.

  • Percentage Held by Institutions

    54.98% of the stock of ResMed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ResMed's insider trading history.
Receive RMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter.

RMD Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Resmed to Announce Q4 Fiscal 2025 Earnings
See More Headlines

RMD Stock Analysis - Frequently Asked Questions

ResMed's stock was trading at $228.69 at the beginning of 2025. Since then, RMD shares have increased by 12.9% and is now trading at $258.0940.

ResMed Inc. (NYSE:RMD) posted its earnings results on Wednesday, April, 23rd. The medical equipment provider reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.36 by $0.01. The firm's revenue was up 7.9% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of ResMed: Propeller Health, and Matrixcare.

ResMed's top institutional shareholders include Swedbank AB (0.30%), Confluence Investment Management LLC (0.08%), MassMutual Private Wealth & Trust FSB (0.05%) and Mn Services Vermogensbeheer B.V. (0.04%). Insiders that own company stock include Michael J Farrell, Robert Andrew Douglas, Brett Sandercock, David Pendarvis, Peter C Farrell, Justin Leong, Kaushik Ghoshal, Michael J Rider, Karen Drexler, Lucile Blaise and Witte Jan De.
View institutional ownership trends
.

Shares of RMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ResMed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
4/23/2025
Record date for 6/12 Dividend
5/08/2025
Ex-Dividend for 6/12 Dividend
5/08/2025
Dividend Payable
6/12/2025
Today
7/10/2025
Next Earnings (Estimated)
7/31/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:RMD
CIK
943819
Employees
9,980
Year Founded
1989

Price Target and Rating

High Price Target
$290.00
Low Price Target
$180.00
Potential Upside/Downside
+0.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$8.91
Trailing P/E Ratio
28.97
Forward P/E Ratio
27.25
P/E Growth
1.61
Net Income
$1.02 billion
Net Margins
26.15%
Pretax Margin
31.41%
Return on Equity
25.67%
Return on Assets
18.59%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
3.41
Quick Ratio
2.49

Sales & Book Value

Annual Sales
$4.69 billion
Price / Sales
8.08
Cash Flow
$9.28 per share
Price / Cash Flow
27.81
Book Value
$33.11 per share
Price / Book
7.80

Miscellaneous

Outstanding Shares
146,630,000
Free Float
145,586,000
Market Cap
$37.84 billion
Optionable
Optionable
Beta
0.77

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:RMD) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners